Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q3 2021 · 10-Q
Revenue$0.00$0.00no prior Q3 2020 on file Net Income-$12.67M-$12.67MN/M vs Q3 2020 EPS Diluted-$0.18-$0.18N/M vs Q3 2020 Operating Income-$12,668,937N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,305,807N/M ended Sep 30, 2021 · filed Nov 10, 2021 · 41 d after period end